2026 Retina Report
Download the free report to learn how eyecare professionals are managing retinal disease in 2026!
New Content
Beyond Monotherapy: What the APL-3007 Combination Trial Signals About the Next Phase of Complement Therapy
Join Drs. Rishi P. Singh and Mathew MacCumber as they discuss the clinical results of APL-3007 combined with pegcetacoplan for geographic atrophy (GA).
Assessing and Managing Retinal Tears as an Optometrist
Sit down with Drs. Daniel Epshtein and Jessica Haynes to review how to identify and stage retinal tears as well as decide when to refer high-risk cases.
Topics
The Digital Dilemma: Protecting Pediatric Vision in a Screen-Heavy World
Why the Best Retina Surgeons Keep Adapting Their Technique
Building Effective OD–Retina Specialist Partnerships: Referral and Co-Management Best Practices
Mild NPDR can progress faster than a “see you in a year” plan allows. Learn to spot the early signs, stage accurately, and recognize the risk factors linked to progression. You’ll also review emerging therapy data, know when to refer, and get practical guidance on documentation, co-management, and building stronger relationships with retina specialists.
Innovent's Sycume meets phase 3 endpoint for inactive TED
RESTORE-3 trial demonstrates efficacy in reducing proptosis and a favorable safety profile for patients with inactive TED.
Alcon's Brytly Redness Reliever Drops receive FDA approval
Company reports effects lasting up to 12 hours for the first OTC drop in the U.S. with apraclonidine—50% longer than Lumif
FDA approves RYZUMVI for presbyopia
Phentolamine ophthalmic solution 0.75% now has two indications in the U.S.; commercial launch timeframe is unknown as Viatris seeks a partner.
Leadership watch: Saunders exits B+L, ZEISS names Vision Care CEO, and other executive moves
Step-by-Step Guide to Pupil Testing with Flowchart
Learn how optometrists can approach pupil abnormalities to identify potential causes efficiently and download the diagnostic and management workflow.
An Exploration of the Future of Dry Eye Therapy
Review current and emerging therapies that have the potential to change the dry eye treatment paradigm beyond symptom management to disease modification.
2026 Retina Report
Download the free report to learn how eyecare professionals are managing retinal disease in 2026!
Clinical Specialties
Beyond Monotherapy: What the APL-3007 Combination Trial Signals About the Next Phase of Complement Therapy
Assessing and Managing Retinal Tears as an Optometrist
Benchmarking Your Contact Lens KPIs: What Top-Performing Practices Are Tracking
This article outlines which contact lens KPIs to track, how your optometry practice compares to industry benchmarks, and where to adjust to increase revenue.
Beyond the Sales Rep: Understanding Who’s Who in Industry
Discover who does what inside industry and how knowing the differences can save you time, find research opportunities, address insurance issues, and more.
I Saw It on TV: DTC Pharma Marketing and the New Eyecare Patient
Sit down with Drs. Lang, Garlich, and Dierker to review the impact of direct-to-consumer (DTC) pharmaceutical marketing on eyecare patients.
